Resmed (RMD) Receivables - Other (2018 - 2026)

Resmed's Receivables - Other history runs 9 years deep, the most recent figure standing at $47.1 million for Q1 2026.

• Quarterly Receivables - Other fell 8.77% year-over-year to $47.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.1 million (down 8.77% YoY) and the FY2025 annual result came in at $51.2 million, up 34.03% from the prior year.
• Receivables - Other was $47.1 million for Q1 2026 at Resmed, down from $61.4 million in the prior quarter.
• Across five years, Receivables - Other topped out at $61.4 million in Q4 2025 and bottomed at $23.1 million in Q4 2022.
• A 5-year average of $38.4 million and a median of $37.9 million in 2024 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2022 — Receivables - Other jumped 135.86% — and 2026, when it decreased 8.77%.
• Resmed's Receivables - Other stood at $23.1 million in 2022, then soared by 49.62% to $34.6 million in 2023, then surged by 35.98% to $47.0 million in 2024, then surged by 30.61% to $61.4 million in 2025, then declined by 23.29% to $47.1 million in 2026.
• Business Quant data shows RMD's Receivables - Other at $47.1 million in Q1 2026, $61.4 million in Q4 2025, and $51.1 million in Q3 2025.